PTPRD and oligodendroglioma: PTPRD and CNTNAP2, which are recurrently altered in diffuse gliomas and show decreased expression in a subpopulation of patients, could be informative for the stratification of these aggressive oligodendrogliomas by analyzing their inactivating alterations and gene expression levels.